Newsflash:
- Sanofi Highlights Positive PhIII Study for Myelofibrosis Contender
- Prescription Painkillers Linked to Erectile Dysfunction
- Melanoma Treatment Harnesses Immune System to Combat Cancer Cells
- Gout: No Help From Vitamin C
- FDA Okays New Drug for Castration-Resistant Prostate Cancer
- FDA Approves Genetic Test for Lung Cancer Drug
Amyvid Now Available in Select U.S. Markets
Eli Lilly and Company Press Release (06/01/12)
Eli Lilly and Avid Radiopharmaceuticals, a wholly owned subsidiary of Lilly, have announced that Amyvid (Florbetapir F 18 Injection) is available to imaging centers in markets surrounding 16 manufacturing sites in the United States. Because Amyvid loses over half of its radioactivity every two hours, it must be distributed directly to imaging centers from the specialized radiopharmacies where it is produced.
Abstract News © Copyright 2011
INFORMATION, INC.
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
